Stefano Rossetti

Nomura Securities International, Inc. (NSI) is a registered broker/dealer headquartered in New York City and was founded in 1969. The firm is a division of Nomura Holding America, Inc. and their ultimate parent is Nomura Holdings, Inc. (NYSE: NMR, TYO: 8604, AMS: 8604). NSI provides securities brokerage services, as well as asset management, domestic retail, global markets, global investment banking and global merchant banking services. The firm's fixed-income business consists of bond sales and trading, origination and product supply for securitization deals and real estate-focused asset finance operations (in cooperation with Investment Banking). In the equity markets, NSI offers sales and trading of domestic and foreign stocks on a global basis, primarily for institutional investors.

Eisai China, lnc. engages in the manufacture of pharmaceutical products. It offers medicines for digestive, endocrine, orthopedic, and cancer diseases. The company was founded on March 28, 1996 and is headquartered in Suzhou, China.

Part of Roche (China) Co. Ltd., Shanghai Roche Pharmaceutical Co., Ltd. is a company that manufactures pharmaceutical products. Shanghai Roche Pharmaceutical Co., Ltd. is based in Shanghai, China.

BMO Capital Markets Corp. (Broker) is the broker/dealer division of BMO Capital Markets Corp., a full-service North American financial services provider headquartered in New York City. The firm was founded in 1998 and is a subsidiary of BMO Financial Corp., which is owned by Bank of Montreal (NYSE, TSX: BMO) in Canada. BMO Capital Markets offers corporate, institutional and government clients access to a variety of products and services including equity and debt underwriting, corporate lending and project financing, merger and acquisitions advisory services, merchant banking, securitization, treasury and market risk management, debt and equity research and institutional sales and trading.

Front Line Strategic Consulting, Inc. provides consulting services to pharmaceutical and biotechnology companies. The firm's skill set include corporate strategy, financial analysis and forecasting, in-licensing and business development, market research and analysis, mergers and acquisition, new product planning, operations, manufacturing and packaging, project management, statistical analysis and econometric modeling and technical feasibility. The company was founded by Daniel J. Aguiar in 1992 and is headquartered in San Mateo, CA.

Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ.

Piper Sandler & Co. (Broker) (PSC-Broker) is the full-service brokerage division of Piper Sandler & Co., a financial service firm headquartered in Minneapolis, Minnesota. They are a subsidiary of Piper Sandler Companies (NYSE: PIPR). The firm was founded in 1969 and previously known as Piper Jaffray & Co. They became Piper Sandler & Co. when Piper Jaffray Companies and Sandler O’Neill & Partners, L.P. merged to become Piper Sandler Companies in 2020. PSC-Broker provides brokerage and investment banking services to financial institutions, corporations and other financial investors. Their core focus sectors are Agriculture, renewables & cannabis, Business services, Chemicals & Materials, Consumer, Diversified industrials & services, Energy, Financial services, financial sponsors, Healthcare, and Technology.

National Comprehensive Cancer Network, Inc. provides research and development services to fight against cancer. The organization develops resources that present information to the numerous stakeholders in the health care delivery system. The company was founded in 1995 and is headquartered in Fort Washington, PA.

Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden.

Hunter-Fleming Ltd. dvelops pharmaceutical products. The company was founded by James R. Murray, John S. Fox and Ernst Wülfert in February 1999 and is headquartered in Brixham, the United Kingdom.

Polifarma SpA engages in the manufacture of ethical medicines. It specializes in the provision of pharmaceutical preparations for cardiovascular, gastroenterology, central nervous system, infectious diseases, and pain and inflammation areas. The company was founded in 1919 and is headquartered in Rome, Italy.

Romark Global Pharma LLC engages in the operation of an integrated biopharmaceutical company. The firm specializes in the discovery, development, and commercialization of small molecules for treating infectious diseases and cancers. The company was founded on November 14, 2014 and is headquartered in San Juan, Puerto Rico.

Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA.